Periodic Reporting for period 2 - OUTSOURCE (Outsourcing cancer immunity to healthy donors)

Despite recent success of cancer immunotherapy, most patients with metastatic cancer are not cured. One of the most important reasons is lack of homogeneously and highly expressed molecules that can be safely targeted. CAR T cell therapies are now approved in acute B-cell...